- Home
- RIME vs PPBT Comparison
RIME vs PPBT Comparison
Compare RIME & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIME
- PPBT
- Stock Information
- Founded
- RIME 1982
- PPBT 2010
- Country
- RIME United States
- PPBT Israel
- Employees
- RIME N/A
- PPBT N/A
- Industry
- RIME
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- RIME
- PPBT Health Care
- Exchange
- RIME NYSE
- PPBT Nasdaq
- Market Cap
- RIME 5.8M
- PPBT 6.2M
- IPO Year
- RIME 1994
- PPBT N/A
- Fundamental
- Price
- RIME $2.41
- PPBT $2.40
- Analyst Decision
- RIME Strong Buy
- PPBT Strong Buy
- Analyst Count
- RIME 1
- PPBT 1
- Target Price
- RIME $5.00
- PPBT $33.00
- AVG Volume (30 Days)
- RIME 57.1K
- PPBT 20.0K
- Earning Date
- RIME 08-19-2025
- PPBT 08-15-2025
- Dividend Yield
- RIME N/A
- PPBT N/A
- EPS Growth
- RIME N/A
- PPBT N/A
- EPS
- RIME N/A
- PPBT N/A
- Revenue
- RIME $23,061,000.00
- PPBT N/A
- Revenue This Year
- RIME N/A
- PPBT N/A
- Revenue Next Year
- RIME N/A
- PPBT N/A
- P/E Ratio
- RIME N/A
- PPBT N/A
- Revenue Growth
- RIME N/A
- PPBT N/A
- 52 Week Low
- RIME $1.71
- PPBT $2.00
- 52 Week High
- RIME $230.00
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- RIME N/A
- PPBT 47.27
- Support Level
- RIME N/A
- PPBT $2.35
- Resistance Level
- RIME N/A
- PPBT $2.58
- Average True Range (ATR)
- RIME 0.00
- PPBT 0.12
- MACD
- RIME 0.00
- PPBT 0.01
- Stochastic Oscillator
- RIME 0.00
- PPBT 43.75
About RIME ALGORHYTHM HOLDINGS INC
Algorhythm Holdings Inc is an AI technology and consumer electronics holding company with two primary business units - SemiCab and Singing Machine. SemiCab is an artificial intelligence (AI) enabled software logistics business operated through its subsidiary, SemiCab Holdings, LLC. Singing Machine is a home karaoke consumer products business that designs and distributes karaoke products globally to retailers and eCommerce partners through its subsidiary, The Singing Machine Company, Inc. It generates the majority of its revenue from the Singing Machine business segment.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.